mRNA Concerns

Sasha shares her alarming insights into the suppression of hydroxychloroquine and the introduction of mRNA as a vaccine technology. Drawing from her experience in pharma, she recalls a significant scandal involving a phase one clinical trial that resulted in severe injuries and raised serious safety concerns. This history prompts a deep reflection on the implications of using mRNA for treating critical conditions.